Literature DB >> 10825350

Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey.

S A Broadley1, J Deans, S J Sawcer, D Clayton, D A Compston.   

Abstract

Previous studies examining an association with other autoimmune diseases have suggested the existence of a generalized autoimmune diathesis in patients with multiple sclerosis. We investigated the prevalence of autoimmune disease in first-degree relatives of probands with multiple sclerosis using a case-control method. The results show an excess of autoimmune disease within these families, but no significant association was seen with non-autoimmune diseases. The higher risk in multiplex than simplex families suggests an effect of genetic loading. While the increase in risk applies to each autoimmune disease, autoimmune thyroid disease (and Graves' disease in particular) contributes disproportionately to the excess risk. There was no increase in autoimmune disease within patients with multiple sclerosis themselves when compared with the index controls or population data. We conclude that autoimmune disease is more common in first-degree relatives of patients with multiple sclerosis and hypothesize that common genetic susceptibility factors for autoimmunity co-exist with additional disease specific genetic or environmental factors, which determine clinical phenotype in the individual.

Entities:  

Mesh:

Year:  2000        PMID: 10825350     DOI: 10.1093/brain/123.6.1102

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  55 in total

Review 1.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 2.  Shared autoimmunity: the time has come.

Authors:  Donato Alarcón-Segovia
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

3.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

4.  Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.

Authors:  Lindsey A Criswell; Kirsten A Pfeiffer; Raymond F Lum; Bonnie Gonzales; Jill Novitzke; Marlena Kern; Kathy L Moser; Ann B Begovich; Victoria E H Carlton; Wentian Li; Annette T Lee; Ward Ortmann; Timothy W Behrens; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2005-02-17       Impact factor: 11.025

5.  The genetic aspects of multiple sclerosis.

Authors:  Stephen Sawcer
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

6.  Multiple sclerosis and environmental risk factors: a case-control study in Iran.

Authors:  Maryam Abbasi; Seyed Massood Nabavi; Seyed Mohammad Fereshtehnejad; Nikan Zerafat Jou; Iman Ansari; Vahid Shayegannejad; Seyed Ehsan Mohammadianinejad; Mahdi Farhoudi; Abbas Noorian; Nazanin Razazian; Mahmoud Abedini; Fardin Faraji
Journal:  Neurol Sci       Date:  2017-08-10       Impact factor: 3.307

Review 7.  GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.

Authors:  Matthew J Simmonds
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

Review 8.  [Possibilities and risks of the monoclonal antibody alemtuzumab as a new treatment option for multiple sclerosis].

Authors:  C Warnke; B C Kieseier; U Zettl; H-P Hartung
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

9.  Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders.

Authors:  Nilufer Kale; Murat Icen; Jale Agaoglu; Isil Yazici; Osman Tanik
Journal:  Neurol Sci       Date:  2008-10-14       Impact factor: 3.307

10.  The expanding genetic overlap between multiple sclerosis and type I diabetes.

Authors: 
Journal:  Genes Immun       Date:  2008-11-06       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.